Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magiar Chilena was a Chile-based distributor of food, animal, and plant diagnostic products, including Neogen products, serving customers in agriculture and food safety rather than human therapeutics. The business operated in the broader life science and diagnostic supply chain, with a focus on testing solutions for food and animal safety. In March 2020, Neogen acquired the assets of Magiar Chilena to establish a direct commercial presence in Chile. Following the transaction, the acquired assets were incorporated into Neogen Chile SpA for continued operations in the country.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magier Chilena.